281 related articles for article (PubMed ID: 28839258)
1. BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats.
Wang D; Berglund AE; Kenchappa RS; MacAulay RJ; Mulé JJ; Etame AB
Sci Rep; 2017 Aug; 7(1):9350. PubMed ID: 28839258
[TBL] [Abstract][Full Text] [Related]
2. A Novel Role of BIRC3 in Stemness Reprogramming of Glioblastoma.
Wu Q; Berglund AE; MacAulay RJ; Etame AB
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008722
[TBL] [Abstract][Full Text] [Related]
3. BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.
Wang D; Berglund A; Kenchappa RS; Forsyth PA; Mulé JJ; Etame AB
Sci Rep; 2016 Feb; 6():21710. PubMed ID: 26888114
[TBL] [Abstract][Full Text] [Related]
4. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
[TBL] [Abstract][Full Text] [Related]
5. Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment.
Nigim F; Cavanaugh J; Patel AP; Curry WT; Esaki S; Kasper EM; Chi AS; Louis DN; Martuza RL; Rabkin SD; Wakimoto H
J Neuropathol Exp Neurol; 2015 Jul; 74(7):710-22. PubMed ID: 26083570
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia induces H19 expression through direct and indirect Hif-1α activity, promoting oncogenic effects in glioblastoma.
Wu W; Hu Q; Nie E; Yu T; Wu Y; Zhi T; Jiang K; Shen F; Wang Y; Zhang J; You Y
Sci Rep; 2017 Mar; 7():45029. PubMed ID: 28327666
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis.
Joseph JV; Conroy S; Pavlov K; Sontakke P; Tomar T; Eggens-Meijer E; Balasubramaniyan V; Wagemakers M; den Dunnen WF; Kruyt FA
Cancer Lett; 2015 Apr; 359(1):107-16. PubMed ID: 25592037
[TBL] [Abstract][Full Text] [Related]
8. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy.
Ho KH; Shih CM; Liu AJ; Chen KC
Cancer Sci; 2022 Feb; 113(2):540-552. PubMed ID: 34897892
[TBL] [Abstract][Full Text] [Related]
10. HIF1α and p53 Regulated MED30, a Mediator Complex Subunit, is Involved in Regulation of Glioblastoma Pathogenesis and Temozolomide Resistance.
Shukla A; Srivastava S; Darokar J; Kulshreshtha R
Cell Mol Neurobiol; 2021 Oct; 41(7):1521-1535. PubMed ID: 32705436
[TBL] [Abstract][Full Text] [Related]
11. Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme.
Hsieh CH; Lin YJ; Wu CP; Lee HT; Shyu WC; Wang CC
Clin Cancer Res; 2015 Jan; 21(2):460-70. PubMed ID: 25370472
[TBL] [Abstract][Full Text] [Related]
12.
Shi Y; Jiang J; Cui Y; Chen Y; Dong T; An H; Liu P
DNA Cell Biol; 2021 Jan; 40(1):93-100. PubMed ID: 33181035
[TBL] [Abstract][Full Text] [Related]
13. The genotypic and phenotypic impact of hypoxia microenvironment on glioblastoma cell lines.
Macharia LW; Muriithi W; Heming CP; Nyaga DK; Aran V; Mureithi MW; Ferrer VP; Pane A; Filho PN; Moura-Neto V
BMC Cancer; 2021 Nov; 21(1):1248. PubMed ID: 34798868
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3 up-regulation in hypoxic and nutrient deprived microenvironments promotes cell survival.
Ikemori RY; Machado CM; Furuzawa KM; Nonogaki S; Osinaga E; Umezawa K; de Carvalho MA; Verinaud L; Chammas R
PLoS One; 2014; 9(11):e111592. PubMed ID: 25369297
[TBL] [Abstract][Full Text] [Related]
15. NADPH oxidase subunit 4 mediates cycling hypoxia-promoted radiation resistance in glioblastoma multiforme.
Hsieh CH; Wu CP; Lee HT; Liang JA; Yu CY; Lin YJ
Free Radic Biol Med; 2012 Aug; 53(4):649-58. PubMed ID: 22713363
[TBL] [Abstract][Full Text] [Related]
16. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia, Inflammation and Necrosis as Determinants of Glioblastoma Cancer Stem Cells Progression.
Papale M; Buccarelli M; Mollinari C; Russo MA; Pallini R; Ricci-Vitiani L; Tafani M
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290386
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay.
Marampon F; Gravina GL; Zani BM; Popov VM; Fratticci A; Cerasani M; Di Genova D; Mancini M; Ciccarelli C; Ficorella C; Di Cesare E; Festuccia C
Int J Oncol; 2014 Jun; 44(6):2121-31. PubMed ID: 24676782
[TBL] [Abstract][Full Text] [Related]
19. The angiogenic switch leads to a metabolic shift in human glioblastoma.
Talasila KM; Røsland GV; Hagland HR; Eskilsson E; Flønes IH; Fritah S; Azuaje F; Atai N; Harter PN; Mittelbronn M; Andersen M; Joseph JV; Hossain JA; Vallar L; Noorden CJ; Niclou SP; Thorsen F; Tronstad KJ; Tzoulis C; Bjerkvig R; Miletic H
Neuro Oncol; 2017 Mar; 19(3):383-393. PubMed ID: 27591677
[TBL] [Abstract][Full Text] [Related]
20. Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.
Kong Y; Feng ZC; Zhang YL; Liu XF; Ma Y; Zhao ZM; Huang B; Chen AJ; Zhang D; Thorsen F; Wang J; Yang N; Li XG
Front Immunol; 2020; 11():1281. PubMed ID: 32765489
[No Abstract] [Full Text] [Related]
[Next] [New Search]
